News Newsroom. VBID Newsletter. Journals About.
Breast cancer is the leading cause of cancer in females between the ages of 15 and 54, and the second leading cause of cancer death in women in the United States. Diagnosis begins with detection by breast examination clinical breast exam or breast self-exam or by radiologic studies, like mammography. Many advances in the diagnosis of breast cancer have taken place in recent years.
NCBI Bookshelf. To the extent that it was possible, the committee evaluated the apparent strengths and weaknesses of the new breast cancer detection technologies. However, the experimental evidence available for most new breast cancer detection technologies was not strong enough to support definitive conclusions about their ultimate clinical value and use, as discussed below.
Researchers around the world are working to find better ways to preventdetectand treat breast cancer, and to improve the quality of life of patients and survivors. Studies continue to uncover lifestyle factors and habits, as well as inherited genes, that affect breast cancer risk. Here are a few examples:. Researchers continue to look for medicines that might help lower breast cancer risk, especially women who are at high risk.
Purdue University researchers have developed a new technology that may change how one of the most aggressive types of breast cancer is treated. More thancases of breast cancer are diagnosed each year in the United States. The most aggressive type of breast cancerknown as triple negative breast cancer TNBCdisproportionately affects young premenopausal women of African-American or Hispanic descent.
The outlook for finding and dealing with breast cancer has improved dramatically, and will continue to improve exponentially. Mammomat Fusion is the latest addition to the Siemens family of full-field digital mammography systems that offers premium product features to address the specific needs of volume screening centers and small to medium-sized hospitals. Fujifilm Medical Systems digital breast tomosynthesis module will be offered as an optional upgrade for the Aspire Cristalle mammography system.
The major factors for the growth of the mammography market include the growing prevalence of breast cancer, technological advancements in the field of breast imaging, and investment from various organizations in breast cancer screening campaigns. The Center for Disease Control CDC reports breast cancer to be one of the most common cancers among women, irrespective of race or ethnicity. According to the estimates of the National Cancer Institute NCI, new cases and 40, deaths were registered due to breast cancer in
NCI-funded researchers are working to advance our understanding of how to prevent, detect, and treat breast cancer. They are also looking at how to address disparities and improve quality of life for survivors of the disease. MRI magnetic resonance imagingultrasoundand clinical breast exams are also used to detect breast cancer, but not as routine screening tools.